# Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease

> **NCT04623619** · NA · UNKNOWN · sponsor: **Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo** · enrollment: 100 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** Acetyl L-Carnitine

## Key facts

- **NCT ID:** NCT04623619
- **Lead sponsor:** Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-15
- **Primary completion:** 2021-04-29
- **Final completion:** 2021-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04623619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04623619, "Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04623619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*